g(m1)-ganglioside and Spondylitis--Ankylosing

g(m1)-ganglioside has been researched along with Spondylitis--Ankylosing* in 1 studies

Other Studies

1 other study(ies) available for g(m1)-ganglioside and Spondylitis--Ankylosing

Article	Year
Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers. Neurology, 2005, Apr-26, Volume: 64, Issue:8 Tumor necrosis factor-alpha (TauNuFalpha) blockers are effective in the treatment of inflammatory arthritis but can induce autoimmune disorders including multiple sclerosis. Described are two patients who developed chronic inflammatory demyelinating polyneuropathy after initiation of anti-TNFalpha treatment. Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Etanercept; Female; G(M1) Ganglioside; Humans; Immunoglobulin G; Infliximab; Male; Middle Aged; Muscle Weakness; Neural Conduction; Peripheral Nerves; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Receptors, Tumor Necrosis Factor; Recovery of Function; Sensation Disorders; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha	2005

Article

Year

Neuropathy resembling CIDP in patients receiving tumor necrosis factor-alpha blockers.

Neurology, 2005, Apr-26, Volume: 64, Issue:8

Tumor necrosis factor-alpha (TauNuFalpha) blockers are effective in the treatment of inflammatory arthritis but can induce autoimmune disorders including multiple sclerosis. Described are two patients who developed chronic inflammatory demyelinating polyneuropathy after initiation of anti-TNFalpha treatment.

Topics: Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Etanercept; Female; G(M1) Ganglioside; Humans; Immunoglobulin G; Infliximab; Male; Middle Aged; Muscle Weakness; Neural Conduction; Peripheral Nerves; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Receptors, Tumor Necrosis Factor; Recovery of Function; Sensation Disorders; Spondylitis, Ankylosing; Tumor Necrosis Factor-alpha

2005